Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
Titel:
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
Auteur:
Chavez, Julio C. Piris-Villaespesa, Miguel Dalia, Samir Powers, John Turba, Elyce Nodzon, Lisa Komrokji, Rami Sokol, Lubomir Locke, Frederick L. Lancet, Jeffrey Sotomayor, Eduardo M. Kharfan-Dabaja, Mohamed A. Pinilla-Ibarz, Javier